Nestle Health Science, which was set up in 2011 as the Swiss-based firm seeks to profit from growing demand for medical foods from an ageing population, said it was not disclosing terms of the deal, which is subject to regulatory approval.
Pamlab, which was founded in 1987 and employs over 300 staff, makes medical foods for patients with conditions including diabetic peripheral neuropathy, dementia, depression and high-risk pregnancy.
"Pamlab will particularly strengthen our brain health platform and provide us an additional foothold in metabolic health in the US," Luis Cantarell, head of Nestle Health Science, said in a statement.
http://www.businesstimes.com.sg/breaking-news/companies-world/nestle-buys-us-medical-foods-firm-pamlab-20130226